What question did this study set out to answer?

To evaluate the efficacy and safety of supermicrosurgical lymphaticovenular bypass for managing secondary upper limb lymphedema following breast cancer therapy.

September 1, 2010Plastic & Reconstructive Surgery

Lymphaticovenular Bypass for Lymphedema Management in Breast Cancer Patients: A Prospective Study

View Full Paper

Ask AI

Bookmark

Authors

DCDavid W. ChangUniversity of Illinois Chicago

Discussion

Member takes

Implication

Prospective study reveals that lymphaticovenular bypass reduces arm swelling in breast cancer patients, indicating effective surgical management for chronic lymphedema.

Key Points

To evaluate the efficacy and safety of supermicrosurgical lymphaticovenular bypass for managing secondary upper limb lymphedema following breast cancer therapy.
Prospective study of 20 breast cancer patients (mean age: 54 years; mean lymphedema duration: 4.8 years) with upper limb lymphedema who received lymphaticovenular bypass using supermicrosurgical techniques.
All patients previously underwent axillary lymph node dissection and 16 received radiation therapy; evaluations included qualitative assessments and volumetric arm measurements at 1, 3, 6, and 12 months postoperatively (mean follow-up: 18 months).
Subjective symptom improvement occurred in 95 percent (19/20) of patients, and 13 patients demonstrated measurable quantitative volume reductions.
Mean limb volume differential reduction was 29 percent at 1 month, 36 percent at 3 months, 39 percent at 6 months, and 35 percent at 1 year post-procedure.
Patients underwent an average of 3.5 bypasses (range, 2 to 5) with hospital stays under 24 hours, and zero postoperative complications or lymphedema exacerbations were observed.

Cite This Study

David W. Chang (2010) studied this question.

synapsesocial.com/papers/6a7dc1e58b7e38892f150998 https://doi.org/10.1097/prs.0b013e3181e5f6a9

View Full Paper

Ask AI

Bookmark

Implication

Prospective study reveals that lymphaticovenular bypass reduces arm swelling in breast cancer patients, indicating effective surgical management for chronic lymphedema.

Lymphaticovenular Bypass for Lymphedema Management in Breast Cancer Patients: A Prospective Study

Discussion

Member takes

Implication

Key Points

Cite This Study

Lymphaticovenular Bypass for Lymphedema Management in Breast Cancer Patients: A Prospective Study

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider